Daiichi Sankyo Europe GmbH

Daiichi Sankyo Co., Ltd. is a Japanese pharmaceutical company, one of the twenty largest in the world in terms of sales. The second largest pharmaceutical company in Japan.

Daiichi Sankyo Inc. (DSI) started operations in the US in 2006. It is a US subsidiary of Daiichi Sankyo Company, Limited and a member of the Daiichi Sankyo Group. The organization, which includes US commercial operations and global clinical development (Daiichi Sankyo Pharma Development), is headquartered in Basking Ridge, New Jersey.

Daiichi Sankyo is headquartered in Tokyo.

Daiichi Sankyo Europe, GmbH (DSE), the European subsidiary, is headquartered in Munich. The organization is responsible for development and production in 12 European countries.

The company owns American biotech company Plexxikon, German biotech company U3 Pharma and recently sold Ranbaxy Laboratories in India.

Daiichi Sankyo Company, Limited is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA).